Global spending on innovation initiatives now exceeds US$350 billion annually, according to the European Commission. Yet Capgemini reports that 90 percent of corporate innovation labs never produce a scalable outcome. The gap between these numbers is filled by a steady stream of workshops, demos, and press releases that create the appearance of progress but rarely translate into operational results.
The Number Behind the Buzzwords
Manufacturing has adopted the language of innovation as readily as any sector: innovation labs, digital accelerators, hackathons, cross-functional teams. The activity is visible. What is less clear is whether any of it survives the transition to the factory floor. The 90 percent failure rate for corporate innovation labs is not an outlier. It comes from Capgemini's research within the industry itself and is consistent across sectors, including manufacturing.
Why Pilots Die on Contact With the Factory Floor
Researchers often point to the corporate immune system as the main reason for repeated failure. Pilots can show promise in controlled settings, with dedicated budgets and sponsors, but little production pressure. The breakdown occurs when these pilots are handed to operational units for scaling. Middle management, measured and rewarded on existing revenue, quality, and short-term output, sees new processes or technologies as operational risk, not opportunity. This is a rational response to the incentives in place, and it leads to the familiar pattern: pilots cycle endlessly, tested but rarely commercialized.
The core issue is not creativity, technical skill, or lack of capital. The real failure is in aligning incentives between those running pilots and the operational leaders responsible for scaling and absorbing disruption.
The Vanity Metrics That Give It Away
Innovation theatre is easy to spot in how programs measure success. When financial outcomes and scalable impact are missing, organizations substitute activity metrics: workshops held, prototypes built, ideas generated, patents filed. These numbers fill review decks but say little about whether anything shipped or whether the business changed.
The underlying problem becomes clear when you review outcome data. A 2025 Gartner survey of over 500 technology leaders found that 72 percent of organizations are breaking even or losing money on AI investments, even as adoption is widespread. Another 2025 report found that 87 percent of respondents see turning ideas into business outcomes as their main obstacle, ahead of funding, technical capability, and talent. Workshops continue. Prototypes accumulate. Few projects reach production.
What the Correction Actually Looks Like
Genuine evidence shows that at least some organisations are correcting course, and the shift is measurable in what they choose to track. Since 2015, the use of patent and intellectual property counts as a primary innovation success metric has declined by roughly 7 percent, while real-time tracking of commercialisation progress and time-to-market has increased. Since 2015, reliance on patent and IP counts as primary innovation metrics has declined by about 7 percent, while tracking commercialization progress and time-to-market has increased by 150 percent. This shift moves attention from defensible activity to metrics that reflect actual market outcomes. Organizations using outcome-based KPIs report innovation returns more than twice as high as those relying on activity counts.s success. Equally telling is an organization's product kill rate, how actively and how quickly it stops projects that are not working. Counterintuitively, a healthy willingness to kill pilots is one of the strongest available signals that an innovation function is being held to genuine accountability rather than simply generating activity nobody is willing to end formally.
What Manufacturing Leaders Should Actually Ask
For executives assessing whether their innovation function is building real capability or just activity, a few questions matter more than any dashboard. What share of KPIs track business outcomes—margin, cycle time, defect rate—versus activity counts like workshops or prototypes? Was an operational leader with budget responsibility involved from the start, or only brought in for sign-off? And most importantly: what projects has this program actively killed in the past year, and is that number tracked?
An innovation program with no project terminations and a metrics deck full of activity counts is not a sign of success. Across a US$350 billion global spending category, this is one of the clearest signals that the underlying issues remain unaddressed.
Is your organization's innovation program measured by outcomes reaching production, or by activity that looks good in a review deck? CEO Outlook Magazine wants to hear your perspective — share your view with our editorial team. If your organization's innovation program is measured by outcomes reaching production rather than activity metrics, the distinction is worth noting. The difference between real progress and activity for its own sake remains central to the manufacturing innovation challenge.
